These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. Egashira N; Matsuda T; Koushi E; Mishima K; Iwasaki K; Shoyama Y; Fujiwara M Eur J Pharmacol; 2006 Nov; 550(1-3):117-22. PubMed ID: 17022969 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats. Tseng AH; Harding JW; Craft RM Behav Brain Res; 2004 Sep; 154(1):77-83. PubMed ID: 15302113 [TBL] [Abstract][Full Text] [Related]
5. A major metabolite of delta 1-tetrahydrocannabinol reduces its cataleptic effect in mice. Burstein S; Hunter SA; Latham V; Renzulli L Experientia; 1987 Apr; 43(4):402-3. PubMed ID: 3032669 [TBL] [Abstract][Full Text] [Related]
6. Delta 9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. Klein TW; Newton C; Widen R; Friedman H J Pharmacol Exp Ther; 1993 Nov; 267(2):635-40. PubMed ID: 7504099 [TBL] [Abstract][Full Text] [Related]
7. The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord. Pugh G; Smith PB; Dombrowski DS; Welch SP J Pharmacol Exp Ther; 1996 Nov; 279(2):608-16. PubMed ID: 8930163 [TBL] [Abstract][Full Text] [Related]
8. Elevation of brain prostaglandin E2 levels in rodents by delta 1-tetrahydrocannabinol. Hunter SA; Audette CA; Burstein S Prostaglandins Leukot Essent Fatty Acids; 1991 Jul; 43(3):185-90. PubMed ID: 1651514 [TBL] [Abstract][Full Text] [Related]
9. Studies on the agonistic activity of delta 9-11-tetrahydrocannabinol in mice, dogs and rhesus monkeys and its interactions with delta 9-tetrahydrocannabinol. Beardsley PM; Scimeca JA; Martin BR J Pharmacol Exp Ther; 1987 May; 241(2):521-6. PubMed ID: 3033218 [TBL] [Abstract][Full Text] [Related]
10. Modulation of Delta9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromatase. Takeda S; Yamamoto I; Watanabe K Toxicology; 2009 May; 259(1-2):25-32. PubMed ID: 19428940 [TBL] [Abstract][Full Text] [Related]
11. Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain. Reichman M; Nen W; Hokin LE Mol Pharmacol; 1987 Nov; 32(5):686-90. PubMed ID: 2824983 [TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of 1-Trans-Delta(9)-Tetrahydrocannabinol (CAS No. 1972-08-3) in F344 Rats and B6C3F1 Mice (Gavage Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1996 Nov; 446():1-317. PubMed ID: 12594529 [TBL] [Abstract][Full Text] [Related]
13. The oral activity of delta'-tetrahydrocannabinol and its dependence on prostaglandin E2. Fairbairn JW; Pickens JT Br J Pharmacol; 1979 Nov; 67(3):379-85. PubMed ID: 574040 [TBL] [Abstract][Full Text] [Related]
14. Targeted deletion of cannabinoid receptors CB1 and CB2 produced enhanced inflammatory responses to influenza A/PR/8/34 in the absence and presence of Delta9-tetrahydrocannabinol. Buchweitz JP; Karmaus PW; Williams KJ; Harkema JR; Kaminski NE J Leukoc Biol; 2008 Mar; 83(3):785-96. PubMed ID: 18073275 [TBL] [Abstract][Full Text] [Related]
15. Metabolic disposition of delta 8-tetrahydrocannabinol and its active metabolites, 11-hydroxy-delta 8-tetrahydrocannabinol and 11-oxo-delta 8-tetrahydrocannabinol, in mice. Watanabe K; Yamamoto I; Oguri K; Yoshimura H Drug Metab Dispos; 1981; 9(3):261-4. PubMed ID: 6113937 [TBL] [Abstract][Full Text] [Related]
16. IL-1 beta and TNF alpha modulate delta 9-tetrahydrocannabinol-induced catalepsy in mice. Gibertini M; Newton C; Friedman H; Klein TW Pharmacol Biochem Behav; 1995 Feb; 50(2):141-6. PubMed ID: 7740051 [TBL] [Abstract][Full Text] [Related]
17. Characterization of a monoclonal antibody that neutralizes the activity of prostaglandin E2. Mnich SJ; Veenhuizen AW; Monahan JB; Sheehan KC; Lynch KR; Isakson PC; Portanova JP J Immunol; 1995 Nov; 155(9):4437-44. PubMed ID: 7594605 [TBL] [Abstract][Full Text] [Related]
18. delta 9-Tetrahydrocannabinol decreases turnover of brain histamine. Oishi R; Itoh Y; Nishibori M; Saeki K J Pharmacol Exp Ther; 1985 Feb; 232(2):513-8. PubMed ID: 2578567 [TBL] [Abstract][Full Text] [Related]
19. Modulation of airway responses to influenza A/PR/8/34 by Delta9-tetrahydrocannabinol in C57BL/6 mice. Buchweitz JP; Karmaus PW; Harkema JR; Williams KJ; Kaminski NE J Pharmacol Exp Ther; 2007 Nov; 323(2):675-83. PubMed ID: 17726158 [TBL] [Abstract][Full Text] [Related]